Standpoint Research Downgrades Sanofi-Aventis (SNY) to Hold; Valuation Call

Article Stock Quotes (1) Comments (0)

Standpoint Research downgraded Sanofi-Aventis (NYSE: SNY) from Buy to Hold.

Analyst, Ronnie Moas, said, "Sanofi shares have crossed our price target for 2012 and are nearing a four-year high. We can no longer leave our highest recommendation attached to this name now at a 52-week high, nearing an all-time high and 25% off the June 1 intra-day low."

For an analyst ratings summary and ratings history on Sanofi-Aventis click here. For more ratings news on Sanofi-Aventis click here.

Shares of Sanofi-Aventis closed at $40.02 yesterday, with a 52 week range of $30.98-$41.13.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Wedbush Downgrades salesforce.com (CRM) to Neutral
• Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
• UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'

Create E-mail Alert Related Categories

Downgrades

Related Entities

Standpoint Research

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?